A Goldman Sachs analyst has lowered price targets for two medical device makers and added a third sell-rated company to its "Americas Conviction" list after forecasting slow growth for implantable cardioverter defibrillators. Analyst David H. Roman lowered 12-month price targets on Boston Scientific Corp. to $9 from ...

WASHINGTON (Reuters) - Researchers announced a new project on Monday to sequence all the genes in childhood tumors to try to discover previously unknown causes of cancer. They also hope they can use the research to help tailor treatments for children, to spare them radiation and chemotherapy that may do them little good. The collaboration between St. Jude Children's Research ...

St. Jude Medical Inc. said Friday it opened a learning center in Belgium to teach doctors about treatments for heart disease. The curriculum at the Brussels facility will include treatments for irregular or slow heart rhythms, valve replacement and repair, vein closure, and repair of the septum ...